logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of CTI BioPharma Corp. Q3 Earnings Report

Below are the earnings highlights for CTI BioPharma Corp. (CTIC):

-Earnings: -$11.26 million in Q3 vs. -$10.05 million in the same period last year.
-EPS: -$0.15 in Q3 vs. -$0.17 in the same period last year.
-Analysts projected -$0.15 per share

For comments and feedback contact: editorial@rttnews.com

RELATED NEWS
Follow RTT